SCHEMBL14934299

SCHEMBL14934299

COc1ccc(I)cc1C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.42
HTR2C P28335 2/20 0.42
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
S1PR1 P21453 1/20 0.39
CTSS P25774 3/20 0.38
CTSK P43235 3/20 0.38
ABCB1 P08183 2/20 0.38
ABCG2 Q9UNQ0 2/20 0.38
ABCC1 P33527 1/20 0.38
NR3C1 P04150 2/20 0.38
PGR P06401 1/20 0.38
NR3C2 P08235 1/20 0.38
P2RX7 Q99572 1/20 0.37
AR P10275 3/20 0.36
HTR2B P41595 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14698940 0.84 HTR2A (0.44) HTR2AHTR2CALDH1A1HPGDHSD17B10
SCHEMBL19186313 0.82 TRPA1 (0.39) HTR2AHTR2CALDH1A1HPGDHSD17B10
SCHEMBL6479519 0.82 LMNA (0.47) HTR2AALDH1A1HPGDNR3C2
SCHEMBL11991670 0.80 RXRA (0.36) HTR2AHTR2CS1PR1CTSS
SCHEMBL12422332 0.78 CA12 (0.56) HTR2AHTR2CALDH1A1PGRAR
SCHEMBL764998 0.78 ACHE (0.56) HTR2AHTR2CALDH1A1HPGDHSD17B10
SCHEMBL13881957 0.78 L3MBTL1 (0.49) HTR2AHTR2CALDH1A1HPGDHSD17B10
SCHEMBL29775318 0.78 CA12 (0.56) HTR2AHTR2CALDH1A1PGRAR
SCHEMBL13347573 0.78 NR3C2 (0.49) NR3C1PGRNR3C2
SCHEMBL130594 0.76 GAA (0.55) HTR2AHTR2CALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2776398-B1 SUBSTITUTED PYRAZOLYL-BASED UREA DERIVATIVES AS VANILLOID RECEPTOR LIGANDS MEDIFRON DBT INC (KR) 2020-09-02 EP disclosed
EP-3224252-B1 SUBSTITUTED OXAZOLE- AND THIAZOLE-BASED CARBOXAMIDE AND UREA DERIVATIVES AS VANILLOID RECEPTOR LIGANDS II MEDIFRON DBT INC (KR) 2019-01-09 EP disclosed
EP-1805158-B1 SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS MODULATORS OF PPAR KALYPSYS INC (US) 2018-06-27 EP disclosed
WO-2013067248-A1 BENZOXAZINES AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-05-10 WO disclosed